February 14, 2025

Board of Directors

Review and approval of KPIs* for Q4 2024

————————————————————————————-

April 30, 2025

Board of Directors

Approval of the annual financial statements and the consolidated group financial statements as of December 31, 2024

————————————————————————————-

May 14, 2025

Board of Directors

Review and approval of KPIs* for Q1 2025

————————————————————————————-

May 29, 2025

Ordinary Shareholders’ Meeting

Approval of the financial statements as of December 31, 2024

———————————————————————————

August 1, 2025

Board of Directors

Review and approval of KPIs* for Q2 2025

————————————————————————————-

September 19, 2025

Board of Directors

Approval of the consolidated half-year financial report as of June 30, 2025, voluntarily subjected to limited audit

————————————————————————————-

November 14, 2025

Board of Directors

Review and approval of KPIs* for Q3 2025

————————————————————————————-

February 13, 2026

Board of Directors

Review and approval of KPIs* for Q4 2025

*The monitored KPIs will be Consolidated Net Sales, Total Consolidated Revenues, Consolidated Net Financial Position, Consolidated Order Backlog, and Consolidated EBITDA – consolidated management data not subject to audit